Monday, April 16, 2007

Boston: return to heaven?


After several problems, Boston Scientific is returning from hell:
  • Reshuffle the board governance.
  • FDA warnings.
  • Stents quality.

Can we take it for granted? Or the Guidant purchase still is the major obstacle?

No comments: